Portal de Periódicos da CAPES

Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors

2016; Elsevier BV; Volume: 43; Linguagem: Inglês

10.1016/j.ymben.2016.11.005

1096-7184

Doriane Lorendeau, Gianmarco Rinaldi, Ruben Boon, Pascal Spincemaille, Kristine L. Metzger, Christian Jäger, Stefan Christen, Xiangyi Dong, Sabine Kuenen, Karin Voordeckers, Patrik Verstreken, David Cassiman, Pieter Vermeersch, Catherine M. Verfaillie, Karsten Hiller, Sarah‐Maria Fendt,

Glioma Diagnosis and Treatment

Mutations in succinate dehydrogenase (SDH) are associated with tumor development and neurodegenerative diseases. Only in tumors, loss of SDH activity is accompanied with the loss of complex I activity. Yet, it remains unknown whether the metabolic phenotype of SDH mutant tumors is driven by loss of complex I function, and whether this contributes to the peculiarity of tumor development versus neurodegeneration. We addressed this question by decoupling loss of SDH and complex I activity in cancer cells and neurons. We found that sole loss of SDH activity was not sufficient to recapitulate the metabolic phenotype of SDH mutant tumors, because it failed to decrease mitochondrial respiration and to activate reductive glutamine metabolism. These metabolic phenotypes were only induced upon the additional loss of complex I activity. Thus, we show that complex I function defines the metabolic differences between SDH mutation associated tumors and neurodegenerative diseases, which could open novel therapeutic options against both diseases.